Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06552481 · ClinicalTrials.gov registry record · NA

A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects

A NA study of Skin Wound and Soft Tissue Injuries, sponsored by The Metis Foundation.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT06552481 is a NA study of Skin Wound and Soft Tissue Injuries that has completed, run by The Metis Foundation. The registered enrollment target is 28 participants, above the 19-participant average among 5 other Skin Wound trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06552481, a NA study of Skin Wound and Soft Tissue Injuries, has completed, sponsored by The Metis Foundation.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.

Interventions

  • DEVICE NP-PWD
  • DEVICE Wound Vac

Study Locations (1)

Texas

  • Northeast Baptist - San Antonio

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2023-08-16
Est. Completion 2024-04-25
Phase NA

Sponsor

The Metis Foundation

8 total trials

What the Registry Record Tells You About NCT06552481

The ClinicalTrials.gov registry entry for NCT06552481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 19-participant average among 5 other Skin Wound trials with a reported enrollment target (47% higher). The listed sponsor is The Metis Foundation, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Skin Wound appearing as the primary indexed condition, and to 2 interventions - of which NP-PWD is the first listed.

NCT06552481 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06552481 about?

NCT06552481 is a clinical study titled "A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects". This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.

What is the current status of trial NCT06552481?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-08-16. Estimated completion is 2024-04-25.

What conditions does trial NCT06552481 study?

This clinical trial studies the following conditions: Skin Wound, Soft Tissue Injuries.

What interventions are being tested in trial NCT06552481?

The interventions under investigation include: NP-PWD (DEVICE), Wound Vac (DEVICE).

Who is sponsoring clinical trial NCT06552481?

This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06552481 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.